Overall Status

Recruiting (2)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 3 (1)

phase 4 (1)

Sponsor

National Cancer Institute (NCI) (2)

Vanderbilt-Ingram Cancer Center (1)

Collaborator

Study Documents

Intervention Type

drug (3)

other (1)

procedure (1)

Funder Type

NIH (2)

Other (1)

Study Type

Interventional (3)

metastatic digestive system neuroendocrine neoplasm

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Digestive System Neuroendocrine Tumor G1, Digestive System Neuroendocrine Tumor G2, Metastatic Digestive System Neuroendocrine

Not yet recruiting

Digestive System Neuroendocrine Tumor G1
+5 more

Tumor Debulking
+5 more

Nashville, Tennessee

Vanderbilt University/Ingram Cancer Center

Aug 23, 2023

Metastatic Digestive System Neuroendocrine Tumor, Metastatic Neuroendocrine Tumor Trial in United States (Lutetium Lu 177

Recruiting

Metastatic Digestive System Neuroendocrine Neoplasm
Metastatic Neuroendocrine Tumor

Lutetium Lu 177 Dotatate
Triapine

Phoenix, Arizona
+10 more

Aug 23, 2022

Atypical Carcinoid Tumor, Carcinoid Tumor, Functioning Pancreatic Neuroendocrine Tumor Trial in United States (Cabozantinib

Recruiting

Atypical Carcinoid Tumor
+18 more

Cabozantinib S-malate
+3 more

Anchorage, Alaska
+425 more

Aug 12, 2022